ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,244.00
1.57%
Dow Jones
38,239.66
0.40%
Brent Oil
88.165
0.00%
Bitcoin
62,867.85
-1.37%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cardio Diagnostics Holdings Inc (CDIO) Quote

Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc (CDIO)

NASDAQ
0.69
-0.0324
(-4.49%)
Closed April 27 4:00PM
Delayed by 15 minutes
0.683
-0.007
(-1.01%)
After Hours: 6:26PM
Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.683
Bid
0.6603
Ask
0.69
Volume
449,811
0.65 Day's Range 0.7399
0.171 52 Week Range 3.56
Market Cap
14.157M
Previous Close
0.7224
Open
0.73
Last Trade
69
@
0.69
Last Trade Time
Financial Volume
$ 309,022
VWAP
0.687005
Average Volume (3m)
478,905
Shares Outstanding
20,516,940
Dividend Yield
-
PE Ratio
-1.69
Earnings Per Share (EPS)
-0.41
Revenue
17k
Net Profit
-8.38M

About Cardio Diagnostics Holdings Inc

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Show more

Sector
In Vitro,in Vivo Diagnostics
Industry
In Vitro,in Vivo Diagnostics
Headquarters
Dover, Delaware, USA
Founded
1970
Cardio Diagnostics Holdings Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was $0.72. Over the last year, Cardio Diagnostics shares have traded in a share price range of $ 0.171 to $ 3.56.

Cardio Diagnostics currently has 20,516,940 shares outstanding. The market capitalization of Cardio Diagnostics is $14.16 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -1.69.

CDIO Latest News

More News

Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan

Exponential Health, an innovative concierge medicine practice in Michigan, adopts Cardio Diagnostics' AI-driven epigenetic-genetic tests, marking a new era in personalized and preventive cardiac...

April 09 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announces a strategic partnership with Navierre, an innovative digital health technology...

April 04 2024
Business Wire

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announces that the Company will showcase its groundbreaking HeartRiskTM and Actionable...

March 14 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Company Continues to Build and Expand the Global IP Portfolio of Its One-of-a-Kind Technology Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine...

March 05 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Transformative Cardiovascular Risk Management Solutions Extend Beyond Traditional Sectors to Include Federal and State Correctional Facilities, Broker and Benefits Organizations, and Risk Bearing...

February 15 2024
Business Wire

Cardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart Supercenters

Agreement is the first introduction of AI-driven epigenetic heart attack risk assessment and coronary heart disease detection tests in a retail healthcare setting on a walk-in basis. Cardio...

February 07 2024
Business Wire

Houston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease Tests

resTOR to be the first longevity clinic nationwide to offer the Company's blood-based epigenetic-genetic cardiovascular disease tests Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an...

February 05 2024
Business Wire

Form DEL AM - Delaying amendment

January 29 2024
Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933

January 26 2024
Edgar (US Regulatory)

Cardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic Advisor

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced the appointment of Dr. Vimal Ramjee, MD FACC CCMS, as a Strategic...

January 24 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.357-34.32692307691.041.060.654574630.7826064CS
4-0.707-50.86330935251.391.430.653429120.9941288CS
12-1.457-68.08411214952.142.40.654789051.55570875CS
260.4862247.0528455280.19683.560.17174891701.35961316CS
52-1.667-70.93617021282.353.560.17138979731.32539521CS
156-3.567-83.92941176474.258.49990.17132928412.05591279CS
260-3.567-83.92941176474.258.49990.17132928412.05591279CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

CDIO Discussion

View Posts
luckydude777 luckydude777 5 days ago
Below $.80 excellant value price.
👍️0
YankeMike YankeMike 1 week ago
Looks like it was because of this:

Benchmark Maintains Speculative Buy on Cardio Diagnostics Hldgs, Lowers Price Target to $1.35
7:47 am ET April 19, 2024 (Benzinga) Print
Benchmark analyst Bruce Jackson maintains Cardio Diagnostics Hldgs (NASDAQ:CDIO) with a Speculative Buy and lowers the price target from $4 to $1.35.
👍️0
rosemountbomber rosemountbomber 1 week ago
North this along with HSCS has taken a beating. Are they going kaput?
👍️0
Triple nickle Triple nickle 1 week ago
Ok bounce time 1.03
👍️0
tw0122 tw0122 1 month ago
Let’s go nice flipper
👍️0
Monksdream Monksdream 1 month ago
CDIO under $2
👍️0
north40000 north40000 2 months ago
A new notice of allowance for a patent application, titled:

Compositions And Methods For Detecting Predisposition To Cardiovascular Disease.
👍️0
rosemountbomber rosemountbomber 2 months ago
There has to be some news that we are not privy to. Huge beat down
👍️0
Monksdream Monksdream 2 months ago
CDIO under $2
👍️0
luckydude777 luckydude777 3 months ago
As expected, Market Makers are loading up on cheap shares before the next run starts. Get 'em while they're cheap, laddies.
👍️0
luckydude777 luckydude777 3 months ago
This could be a HUGE positive marketing move with this morning's news. EASY ACCESS to the test may make all the difference in the world to CDIO. Stay tuned folks ...!!!
👍️0
saigai saigai 3 months ago
there is no other way to interpret the recent ..last 6 weeks of in play.....this is gonna be huge... its coming
👍️0
luckydude777 luckydude777 3 months ago
If their brain/s are working right, they release a good PR, and as the whole world scrambles to pick up shares, they'll start selling their shares at much higher prices.

Appears she is heading higher though, as you say.
👍️0
saigai saigai 3 months ago
todays filing is good news.. they are getting ready to sell some shares but they could have done that at higher prices a bunch of weeks back.. we gonna pop and then monster
👍️0
luckydude777 luckydude777 4 months ago
The dip of the dip of the DIP! Gollllyyyyyyyyyyyyyyyyyyyy ... they sure are trying to shake out the weak, feeble and creating frightattacks.

This could be grounds for a CLASS-ACTION LAWSUIT on behalf of insiders having coronaries.
👍️0
Runners123 Runners123 4 months ago
Buy the dip
👍️0
luckydude777 luckydude777 4 months ago
VERY GOOD news! Company is NOT cash strapped!

"The First Convertible Debenture has been fully repaid, and as of January 4, 2024, the Company’s obligation to issue and sell, and Yorkville’s obligation to purchase, the Second Convertible Debenture has been terminated. At the time of termination, there were no outstanding borrowings, advance notices or shares of Common Stock to be issued under the Securities Purchase Agreement. In addition, there were no fees due by the Company or Yorkville in connection with the termination of the Securities Purchase Agreement.
👍️0
luckydude777 luckydude777 4 months ago
Yep - predictable as the ocean will be wet come sundown.
👍️0
luckydude777 luckydude777 4 months ago
More like I wonder how LOW they'll puke it just to show us that they CAN?
👍️0
luckydude777 luckydude777 4 months ago
Will be interesting to see what kind of upside we get today from the news a bit earlier.
👍️0
saigai saigai 4 months ago
sorry about the post wrong board for sure
👍️0
saigai saigai 4 months ago
building a small position in intc...good value a few bucks i wont have to baby sit
👍️0
luckydude777 luckydude777 4 months ago
I'm in agreement.
👍️0
saigai saigai 4 months ago
it was a great trade on news day for many.. i can only hold.. the real buyers of this news added value will join us before weeks end ..
👍️0
saigai saigai 4 months ago
still moves on a whisper. no dillution yet.. they have had a 100 different opps to sell into strength and they have not..they will offering in double digits or if they are really lucky get some big boy debt financing based on orders. revenue monster..imo
👍️0
Whalatane Whalatane 4 months ago
This is just my opinion as a secondary prevention coronary heart disease patient with a family history of early heart attacks.
Their test is a risk calculator ...not IMHO a diagnostic test.
Diagnostic tests are done if you are in the ER with chest pains and they are doing Tropin tests , EKG readings etc and deciding weither or not to send you to the Cath lab for an angiogram.
CDIO's test is a combination of a DNA test and a lipid panel ....if I have that wrong , please correct.

Have you checked how much cash on hand they have ...chk the latest 10Q...because if they are low on COH ( which they probably are ) they are likely to use this news event to raise cash
Last 10Q they had $4.5m in cash , prepaid expenses etc and were running close to $2m in loss's each Qt
They may have had a cash infusion since that report

Kiwi
👍️0
luckydude777 luckydude777 4 months ago
They can always drop the $350 price of the test. And/or ... insurance companies may come to believe that $350 for the test is MUCH CHEAPER than all the extensive/EXPENSIVE testing for heart conditions the way it is currently being done.
👍️0
Whalatane Whalatane 4 months ago
CHICAGO, January 02, 2024--(BUSINESS WIRE)--Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven precision cardiovascular medicine company, today announced that the American Medical Association (AMA) has assigned a dedicated Current Procedural Terminology (CPT®) Proprietary Laboratory Analysis (PLA), 0440U, for the company’s AI-driven coronary heart disease (CHD) detection test, PrecisionCHD. Receipt of this new CPT PLA code, which will be effective on April 1, 2024, is a significant step toward payer billing and payment, facilitating broader adoption of the first and only integrated genetic-epigenetic diagnostic blood test for CHD.


Congrats on the move.
Doubt if payers or patients will pay the $350 ? the Co wants for this test ...but so far the mkt's buying the hype
No position
Good luck
Kiwi
👍️0
Whalatane Whalatane 4 months ago
North. Happy New Year . Are U still in CDIO and do you have any explanation on current stock movements ...short covering or an actual fundamental story playing out ?
Congrats if you are still in this .
No position
Kiwi
👍️0
Bud-Wiser Bud-Wiser 4 months ago
Sold half of mine @2.65 weeks ago .. she did go all the way back down to like 1.25 and I felt good about it then …but now I’m not feeling so great
👍️0
luckydude777 luckydude777 4 months ago
Now that coding will be set in place (April), the company can NOW release news about OTHER medical facilities who plan to use the test ... or are already administering it.
👍️0
1hot toddy 1hot toddy 4 months ago
too bad u didnt buy when it was 32 cents $$$$$$$$$$
👍️0
UNDAUNTED UNDAUNTED 4 months ago
Sold my stake at 2.36 (at 32 cent loss) but buying back as it drops to lower my avg
👍️0
luckydude777 luckydude777 4 months ago
So it could get shorted back to near $2.00 per A/H.
👍️0
UNDAUNTED UNDAUNTED 4 months ago
So anyone know why this shot up 40% in the last 5 min of trading Friday?
👍️0
S3lfMade S3lfMade 4 months ago
R/S vote today!?
👍️0
luckydude777 luckydude777 4 months ago
Back into CDIO at $2.17. This is where I STICKING for the next several weeks.
👍️0
conix conix 4 months ago
CDIO will be fine come January. Biotech investors are looking forward to more biotech conferences in the new year.
👍️0
UNDAUNTED UNDAUNTED 4 months ago
I'm still holding but you're in a better position than me. I won't even break even until it hits 2.65.
👍️0
Acehole Acehole 4 months ago
Same here. I made a very nice chunk of money selling at 1.83 but damn did I feel stupid when it rocketed up to 2.30 shortly after. Always happens that way.
👍️0
UNDAUNTED UNDAUNTED 4 months ago
So no one knows why this shot up 5 minutes before closing bell?
👍️0
luckydude777 luckydude777 4 months ago
With HUBC ... I feel that is a pretty MEATY PR they released this morning. Of the same caliber of news when CDIO got FDA approval of their testing.

I know this may be stretching things a bit, but my gut feeling is that the government may get behind HUBC behind closed doors. Should that happen down the road, I see HUBC becoming a big-boy stock much more than CDIO, but what the hey do I know???

I DON'T think a person can go wrong holding CDIO shares, that's for SURE. I just don't have enough available cash at the present to hold shares in both companies to make it worth my while sitting in BOTH companies -- at the present anyway.
👍️0
saigai saigai 4 months ago
hubc ill give a look.. i have some powder for monday thanks
👍️0
luckydude777 luckydude777 4 months ago
Noooooooooooooooo ... it went up because I dumped all my CDIO shares earlier before the liftoff and put the proceeds into HUBC. ALWAYS happens that way when I sell a good stock more than not.

I think CDIO has so much potential, but I also think HUBC can have MORE ... depending how things play out. We'll see ...
👍️0
saigai saigai 4 months ago
maybe the movement is the codes are approved..
👍️0
luckydude777 luckydude777 5 months ago
Biding time. Could be a HUGE money maker.
👍️0
saigai saigai 5 months ago
stuck in the mud of a rigged game.. just holding because i know what i own
👍️0
luckydude777 luckydude777 5 months ago
At the rate the share price is getting manipulated down, we'll be kissing a $1.00 (then maybe UNDER that price again) in the not too distant future. Sure hope insiders are LOVING what's happening.

As an old saying goes: It isn't so much what a share of stock is WORTH ... but rather -- "what the price is the MM's and their lap dogs can get it down to before going long on it."
👍️0
luckydude777 luckydude777 5 months ago
Was hoping for some continued upside momentum.
👍️0
Acehole Acehole 5 months ago
What do you mean
👍️0

Your Recent History

NASDAQ
CDIO
Cardio Diagnostics
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved